• Home
• |
• The role of VEGF across tumor types
• |
• VEGF in lung cancer

VEGF and angiogenesis in lung cancer

"...high VEGF levels have been correlated with poor prognosis in patients with lung cancer..."— Herbst et al, J Clin Oncol, 2005¹

As observed in tumor malignancy in general, the process of angiogenesis—and, in particular, vascular endothelial growth factor (VEGF)—may play a critical role in tumor growth and metastasis of lung cancer. It has been shown that

• VEGF is significantly associated with increased microvessel density in lung cancer²
• VEGF is overexpressed in a majority of non-small cell lung cancer (NSCLC) tumors³
• VEGF is expressed at higher levels as lung cancer progresses⁴
• VEGF may be correlated with carcinogens in lung cancer⁵
• VEGF overexpression has been associated with decreased survival in lung cancer^2,6

In this section of ResearchVEGF.com, you will find information on the prevalence of VEGF expression in lung cancer, the relationship between VEGF expression and disease progression, correlation of VEGF with carcinogens, and VEGF as a prognostic factor in lung cancer.

For more information on a specific topic regarding VEGF and angiogenesis in lung cancer, click on the links below:

In This Section

• What evidence is there of VEGF expression in lung cancer?
• What is the prevalence of VEGF expression in lung cancer?
• Is there a relationship between VEGF and carcinogens?
• How does VEGF relate to prognosis in lung cancer?
• Summary of VEGF in lung cancer
• References for VEGF in lung cancer

---

View references
for this site section